Luc-Alain Savoy earned his PhD from the University of Geneva, where he specialized in the application of mass spectrometry for qualitative and quantitative protein analysis. He currently serves as Global Head of Biologics at SGS Pharma, where he leads the strategic development and global positioning of our biologics testing services. In 1991, he co-founded M-Scan SA, a contract research organization focused on advanced bioproduct characterization, which was acquired by SGS in 2010. Luc-Alain brings extensive scientific insight and regulatory expertise to biologics development and analytical innovation.